argenx SE (ARGX) stock
ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$947.52−3.43 (-0.36%)
Close on Nov 17, 2026Market cap –P/E 48.4Yield –
argenx gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2023 it was -231.6%, against -193.5% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -231.6% | −38.1 |
| FY2022 | Dec 31, 2022 | -193.5% | – |
See a number that looks wrong?